Rosemont Pharmaceuticals Holdings to Acquire Aytu Biopharma in All-Cash Deal
AYTU Aytu BioPharma Inc
$2.66 0.00%
View chart & analysis → - 1Rosemont Pharmaceuticals Holdings has entered into a merger agreement with Aytu Biopharma.
- 2The deal is subject to a cash consideration of $2.70 per share for Aytu.
- 3The Aytu board of directors has unanimously approved the transaction.
So what's the key point?
Rosemont Pharmaceuticals Holdings has decided to buy Aytu Biopharma with cash. This means shareholders will receive $2.70 for each share of Aytu.
Source ACCESSWIRE +1 · View original ↗
Nothing hidden: past picks and how they did against the S&P 500.